Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy

• Alice L. den Hertog ,

  * E-mail: a.d.hertog@kit.nl

  Affiliation Royal Tropical Institute (KIT), KIT Biomedical Research, Amsterdam, The Netherlands

  ⨯
• María Montero-Martín,

  Affiliation Liverpool School of Tropical Medicine, Liverpool, United Kingdom

  ⨯
• Rachel L. Saunders,

  Affiliation Liverpool School of Tropical Medicine, Liverpool, United Kingdom

  ⨯
• Matthew Blakiston,

  Affiliation Liverpool School of Tropical Medicine, Liverpool, United Kingdom

  ⨯
• Sandra Menting,

  Affiliation Royal Tropical Institute (KIT), KIT Biomedical Research, Amsterdam, The Netherlands

  ⨯
• Jeevan B. Sherchand,

  Affiliation Tribhuvan University Institute of Medicine, Kathmandu, Nepal

  ⨯
• Lovett Lawson,

  Affiliation Zankli Medical Centre, Abuja, Nigeria

  ⨯
• Olanrewaju Oladimeji,

  Affiliation Zankli Medical Centre, Abuja, Nigeria

  ⨯
• Saddiq T. Abdurrahman,

  Affiliation Abuja Federal Capital Territory Tuberculosis Control Programme, Abuja, Nigeria

  ⨯
• Luis E. Cuevas,

  Affiliation Liverpool School of Tropical Medicine, Liverpool, United Kingdom

  ⨯
• Richard M. Anthony

  Affiliation Royal Tropical Institute (KIT), KIT Biomedical Research, Amsterdam, The Netherlands

  ⨯